Fair Value Calculator Fair Value Calculator
EN DE

DHRUVCA (DHRUVCA) Fair Value & Analysis

IN · Market cap ₹2.6B

D DHRUVCA DHRUVCA · BSE
Price₹357.40
Fair Value₹38.30
Upside-89.3%
Quality45/100
Watch DHRUVCA for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹33.88 – ₹47.88

Fair value as of: Jul 5, 2026

From 14 valuation models · updated today

Share price −18.4% over the past month.

Price vs Fair Value (12 months)

₹445.50 ₹116.70 Fair Value ₹38.30 Jul 2025 Jul 2026

12‑month range ₹116.70 – ₹445.50 · fair‑value band ₹33.88 – ₹47.88 · the ₹357.40 price screens above the ₹38.30 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

DHRUVCA (DHRUVCA) currently trades at ₹357.40, while our model-based Fair Value estimate is ₹38.30 — implying the stock looks roughly 89.3% overvalued today. We read business quality at 45/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, DHRUVCA generated revenue of ₹21.7M at a net margin of 74.7%. Revenue declined 16.9% year over year. It earns a return on equity of 7.7%. Net debt stands at ₹127M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹33.88 (bear case) to ₹47.88 (bull case); at ₹357.40, the current price sits above that range. The share trades about 20% below its 52-week high and 222% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹21.7M
Revenue growth (YoY) -16.9%
Net margin 74.7%
Return on equity 7.7%
Free cash flow −₹115M FY2026
P/E ratio 158.8
More key figures
Operating margin -8.9%
EPS (TTM) ₹2.25
EPS growth (YoY) +1,700%
Net debt ₹127M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

DHRUVCA reported revenue of ₹31.1M in FY2026 versus ₹2.5M in FY2022, a compound +87.0%/yr. Reported net income was ₹16.2M in FY2026, compounding +102.9%/yr from FY2022.

Revenue +87.0%/yr
FY22 ₹2.5M
FY23 ₹2.5M
FY24 ₹11.5M
FY25 ₹21.3M
FY26 ₹31.1M
Net income +102.9%/yr
FY22 ₹956K
FY23 ₹559K
FY24 ₹42.6M
FY25 −₹11.1M
FY26 ₹16.2M

Is DHRUVCA fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "DHRUVCA Fair Value". https://www.fairvalue-calculator.com/stock/DHRUVCA

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is DHRUVCA (DHRUVCA) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹38.30 versus a price of ₹357.40 — about −89% (overvalued). Model-based estimate, not financial advice.
What is the fair value of DHRUVCA?
Our model-based fair value for DHRUVCA is ₹38.30 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹357.40.
What is the quality score of DHRUVCA?
DHRUVCA has a Quality Score of 45/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of DHRUVCA (DHRUVCA)?
DHRUVCA reported trailing-twelve-month revenue of about ₹21.7M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of DHRUVCA?
The net profit margin of DHRUVCA is about 74.7%, meaning it keeps roughly 74.7% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.